Alzheimer's disease (AD) is the major form of dementia prevalent in older adults and with a
high incidence in females. Identification of early biomarkers is essential for preventive …

Abstract Alzheimer's disease (AD), the most common type of dementia, is a
neurodegenerative disorder with a hidden onset, including difficult early detection and …

Alzheimer's disease (AD) is the leading cause of dementia and has become an important
public health concern. Accumulating evidence indicates that estradiol can both facilitate and …

Alzheimer's disease (AD)-related degenerative decline is associated to the presence of
amyloid beta (Aβ) plaque lesions and neuro fibrillary tangles (NFT). However, the precise …

Alzheimer's disease (AD) is the most common progressive neurodegenerative disease and
is associated with dementia. Presently, various chemical and environmental agents are …

Mid-life hypertension and cerebrovascular dysfunction are associated with increased risk of
later life dementia, including Alzheimer's disease (AD). The classical renin–angiotensin …

Alzheimer's disease (AD) is a multifactorial neurological condition associated with a genetic
profile that is still not completely understood. In this study, using a whole gene microarray …

Introduction Epidemiological studies show that women have a higher prevalence of
Alzheimer's disease (AD) than men. Peripheral estrogen reduction during aging in women is …

A sporadic form of Alzheimer disease (AD) and vascular dementia share many risk factors,
and their pathogenic mechanisms are suggested to be related. Transcription factor early …

Alzheimer's disease (AD) is a progressive neurodegenerative disease that is most prevalent
in females. While estrogen provides neuroprotection in females, sex mediated differences in …